Tag Archives: BVDV

Diagnosis, vaccination, and biosecurity to control BVDV

“We must take a three-pronged approach to address the problem: diagnosis, prevention through vaccination and [...]

Vedevax Block Vaccine finalist for the Empretec Award

The world’s first targeted vaccine against the Bovine Viral Diarrhea Virus (BVDV), developed by Bioinnovo, [...]

BVDV, immunosuppression, and its impact on cattle herds

Knowledge about the impact of this virus on production and control measures to mitigate its [...]

Second International Congress on Bovine Viral Diarrhea

In August, Bioinnovo will host the Second International Congress on Bovine Viral Diarrhea Virus (BVDV), [...]

BVDV Differential Diagnosis and Management Strategies

The Workshop “BVDV Differential Diagnosis and Management Strategies” took place as part of the first [...]

Second day of the International Congress on BVDV

The second day of the First International Congress on Bovine Viral Diarrhea Virus (BVDV) was [...]

First International Congress on Bovine Viral Diarrhea Virus

On Monday, July 12, and August 2, 2021, Bioinnovo organizes the First International Congress of [...]

Bioinnovo will increase production of the vaccine against Bovine Viral Diarrhea Virus

Bioinnovo, a public-private partnership between INTA and Vetanco S.A., will allocate an important support, granted by the Ministry [...]

Bioinnovo and Algenex renew agreement for the use of APCH

Bioinnovo, the technology-based public-private company formed by the National Institute of Agricultural Technology (INTA) and [...]

BIOINNOVO IgY DNT OFFICIAL PRESENTATION

May Friday 26th, the date! Official ceremony and technical seminar on Bioinnovo IgY DNT, the first [...]

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.